Reading your scan report
'Residual Disease' — vs 'Complete Metabolic Response'
These two terms appear on your post-treatment PET-CT or MRI report and describe how much cancer activity remained after treatment. Your oncologist uses them to decide the next step in your care.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed September 2026
- Different levels of response — One term means imaging found no remaining activity; the other means something was still visible or active.
- Residual is not always cancer — Scar tissue and dead cells from treatment can appear on a scan in a way that looks similar to living disease.
- Neither term is a final verdict — Your oncologist interprets the result alongside your cancer type, your history, and sometimes a biopsy.
- Next steps depend on the full picture — A good response leads to surveillance; a residual finding leads to further assessment — the detail of what, and when, depends on your specific situation.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
A complete metabolic response means imaging shows no detectable cancer activity after treatment. Residual disease means something was still visible or active on the scan. Neither term is a final verdict — your oncologist interprets both alongside your cancer type, the scan method used, and your overall clinical picture.
What does 'complete metabolic response' mean on your report?
A complete metabolic response, sometimes written as CMR, means the imaging scan detected no remaining cancer activity in the treated area. The areas that were showing uptake before treatment are no longer doing so.
This is the response that treatment aims for. It does not speak to the future — it describes what the scan was able to detect on that specific day, at the sensitivity level of that scan.
Different scans measure different things. A PET-CT measures metabolic activity; an MRI measures size and tissue characteristics. A complete response on one type of scan is described and interpreted differently from a complete response on another.
Is residual disease always active cancer?
Residual disease is not always active cancer. It means the scan found something remaining in the treated area — a shadow, a node, or a mass that had not fully resolved at the time of imaging.
Scar tissue from treatment, dead tumour cells, or inflammation from the body's response can all appear as residual on a scan. This is why the report alone rarely settles the question — your oncologist interprets it in full context.
Whether your team investigates further, watches with a repeat scan, or moves to the next phase of treatment depends on your cancer type, which imaging method was used, and what your earlier scans showed.
How is complete metabolic response different from residual disease?
| Complete metabolic response | Residual disease | |
|---|---|---|
| What the scan shows | No detectable cancer activity in the treated area | Something still visible or metabolically active in the treated area |
| What it means clinically | Treatment reached its imaging goal at this point | Treatment effect was partial, or tissue changes remain to be assessed |
| Does it confirm cancer is gone? | No — imaging has limits and reflects what was detectable on that day | Not necessarily — can be scar tissue, dead cells, or active disease |
| Typical next step | Surveillance scans on a schedule your oncologist sets | Further assessment, biopsy, or continued treatment — depends on context |
| Commonly reported on | PET-CT; some cancers use MRI response criteria | PET-CT, MRI, or CT depending on cancer type and site |
PET-CT Partner Centres
PET-CT Scan Centres in Hyderabad
CION offers PET-CT scans through 4 trusted partner PET-CT centres across Hyderabad, so you can choose the one closest to you. Call 18002028726 and we’ll guide you to the earliest available appointment.
PET-CT Centre — Punjagutta
PET-CT Centre — Himayatnagar
PET-CT Centre — Narayanaguda
These are partner diagnostic centres within the CION network. Toll-free booking: 18002028726.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
You do not have to work this out alone
A 45-minute consultation with a specialist who treats this every week.
What should I ask my doctor about my scan result?
- Ask what type of scan produced this result and what it measures.
- Ask whether 'residual' on your report means active disease or a treatment-related change such as scar tissue.
- Ask what the next scan or test will be, and when it is scheduled.
- Ask what result your team was hoping for going into this scan.
- Ask whether your case is being reviewed at a multidisciplinary team meeting.
- Write down the exact wording from your report to share at your appointment.
What do the other terms on this report mean?
- PET-CT
- A scan that shows where cells in the body are taking up more glucose than usual. Cancer cells often do this more than normal tissue, which is why PET-CT is used to assess treatment response in several cancers.
- Metabolic activity
- The level of chemical activity in a cell or tissue. High metabolic activity on a PET-CT suggests actively functioning cells. Low or absent activity after treatment suggests the area is no longer as active as it was before.
- Deauville score
- A five-point scale used in lymphoma to describe how much activity remains on a PET-CT after treatment, compared with normal reference tissue. Your report may include a number from one to five; your oncologist uses this to guide decisions about next steps.
- SUVmax
- A number on the PET-CT report that measures peak metabolic activity in an area. Your oncologist uses the change in this number between scans — not the number in isolation — to assess how the disease has responded.
- Stable disease
- A third response category — the cancer neither shrank significantly nor grew during treatment. Different from both complete response and progressive disease, and with its own implications for your care plan.
- Progressive disease
- The cancer grew or spread during treatment. This appears in a report as progression, not as residual disease — the two describe different situations and lead to different conversations.
What happens next depending on your result?
If your report says complete metabolic response
Your team will usually move you to a surveillance plan — scans at regular intervals to check that the response is maintained over time. How often and for how long depends on your cancer type and the risk profile your oncologist has discussed with you. A CMR result does not end your relationship with the oncology team; it changes what that relationship focuses on.
If your report says residual disease
Residual disease does not automatically mean your treatment failed or that more intensive treatment begins immediately. Your oncologist will assess whether the finding represents active disease or a treatment-related change such as scarring or inflammation. That may lead to a biopsy, a repeat scan after a short interval, or continuing to the next planned phase of your treatment. The path depends on your cancer type and what the team judges the finding to represent.
If you are unsure what your report says
Ask your oncologist to read the conclusion of the report aloud and explain it in plain language. A report that uses terms you do not understand cannot help you make decisions or manage the anxiety of waiting. Asking for the key finding in one sentence before the appointment moves on is entirely reasonable.
Can a complete response be followed by residual disease on a later scan?
Yes. A complete response on one scan does not guarantee the same finding on the next. This is why surveillance continues after a good response — not because your team doubts the result, but because response is assessed at each scan, not decided once and filed away. A new finding on a later scan would be described and assessed on its own terms.
Does the scan replace a biopsy?
No. Scans show metabolic activity and structural change — they cannot confirm whether cells are alive or dead, cancerous or benign, without tissue examination. Where the nature of a residual finding is genuinely uncertain, a biopsy gives the information a scan cannot. Your oncologist will tell you whether that is needed in your situation.
CION does PET-CT in Hyderabad from Rs 10,499 — among the lowest published prices in the city — including an oncologist-reviewed report and a free Rs 950 consultation. Indicative price, as of September 2026.
Explore 94 more Understanding Your PET-CT Report topics
Reading Your Report: Core Terms
- 'Cannot Be Excluded' and Other Cautious Phrases
- 'Deauville Score' on a Lymphoma PET Report
- 'FDG Avid': What It Means on Your Report
- 'Hypermetabolic': What the Word Actually Means
- 'Hypometabolic' and 'Photopenic' Findings
- 'Impression' vs 'Findings': Which Section Should You Read?
- 'Interval Change' and 'Stable Since Previous Study'
- 'Krenning Score' on a DOTANOC or DOTATATE Report
- 'Lymphadenopathy' on Your PET Report
- 'Metabolically Active Disease': What It Tells You
- 'Metastasis' and 'Distant Spread' on Your Report
- 'Mildly FDG Avid' vs 'Intensely FDG Avid'
- 'No Abnormal FDG Uptake': Is That a Clear Scan?
- 'Physiological Uptake': Normal Areas That Always Light Up
- 'Residual Disease' vs 'Complete Metabolic Response'
- 'Sub-Centimetre Node' and Why Size Matters on PET
- 'Suspicious for Malignancy': How Certain Is That?
- How Long Does a PET-CT Report Take?
- How to Read Your PET-CT Report: A Section-by-Section Guide
- Should You Read Your Own PET-CT Report Before the Consult?
- TNM Staging on a PET-CT Report
- Why Your Report Mentions the Liver and Blood Pool
False Positives, False Negatives & Pitfalls
- Bladder, Kidney and Ureter Activity on PET
- Bone Marrow Uptake After Growth Factor Injections
- Bowel Uptake: Normal, Inflammation or Something Else?
- Brown Fat Uptake: A Common Cause of Confusing Findings
- Does a Suspicious PET Finding Always Need a Biopsy?
- Getting a Second Read of Your PET-CT Images
- How Often Is a PET-CT Scan Wrong?
- Muscle Uptake After Exercise or Injections
- Thymic and Rebound Uptake in Younger Patients
- Uptake After Radiotherapy: Inflammation or Disease?
- Uptake at a Biopsy or Surgery Site
- What Causes a False Negative on a PET Scan?
- What Causes a False Positive on a PET Scan?
- What Happens If Two Scans Disagree?
- Which Cancers Do Not Show Well on PET-CT?
- Why the Brain Always Lights Up on PET
Incidental Findings
- A Second Unrelated Cancer Found on PET-CT
- An Incidental Bone Finding on PET-CT
- An Incidental Breast Finding on PET-CT
- An Incidental Kidney or Adrenal Finding
- An Incidental Liver Lesion on PET-CT
- An Incidental Lung Nodule Found on PET-CT
- An Incidental Prostate Finding on PET-CT
- An Incidental Thyroid Nodule on Your PET Scan
- Do All Incidental Findings Need Investigation?
- Focal Bowel Uptake: Could It Be a Polyp?
- Incidental Findings on a PET-CT Scan: What They Are
- Incidental Heart Findings on a Cancer PET Scan
- The Cost of Chasing an Incidental Finding
- What to Ask Your Doctor About an Incidental Finding
Infection, TB & Inflammation on PET
- Can Tuberculosis Look Like Cancer on a PET Scan?
- Dental Infection and Jaw Uptake on PET
- Fungal Infection and Abscess on PET-CT
- How Long Should You Wait After an Infection Before a PET Scan?
- If It Might Be Infection, What Test Comes Next?
- Inflammation After Injections, Vaccines and Cannulas
- Old Healed TB and Calcified Nodes on PET-CT
- PET-CT for Fever of Unknown Origin
- PET-CT for Suspected Infection in Implants and Prostheses
- PET-CT for Vasculitis and Inflammatory Conditions
- Pneumonia and Recent Chest Infection on PET
- Sarcoidosis on PET-CT: The Great Mimic
- TB or Cancer? How Doctors Tell Them Apart
- Thyroid Uptake on PET: Diffuse vs Focal
Response Assessment Scores & Criteria
- Complete Metabolic Response: What It Means
- Deauville Score 1 to 5: The Lymphoma Scale Explained
- End-of-Treatment PET Scan: What It Decides
- How Doctors Judge Whether Treatment Is Working on PET-CT
- Interim PET Scan During Chemotherapy: Why It Is Done
- Metabolic Response vs Size Response: Why They Differ
- PERCIST Criteria: How Metabolic Response Is Measured
- Partial Metabolic Response: Is That Good Enough?
- Progressive Metabolic Disease: What Happens Next
- RECIST vs PERCIST: Size vs Activity
- Stable Metabolic Disease: Good News or Bad?
- Tumour Flare and Pseudoprogression on PET
- What Is a Deauville 3 and Why Is It Ambiguous?
- Why the Scan Says One Thing and You Feel Another
SUV Values Explained
- Comparing SUV Between Two Scans: Is It Meaningful?
- Does a Higher SUV Mean a More Aggressive Cancer?
- Factors That Change Your SUV Reading
- High SUV but Not Cancer: When the Number Misleads
- Is My SUVmax of 4 High? Reading Your Specific Number
- Low SUV but Still Cancer: The PET-Negative Cancers
- SUV in Non-Cancer Conditions
- SUVmax, SUVmean and SUVpeak: What Is the Difference?
- What Is SUV on a PET Scan?
- What Is a Normal SUV Value?
- What SUV Value Indicates Cancer?
- Why Blood Sugar Changes Your SUV Result
- Why Did My SUV Go Down but Not to Zero?
- Why Did My SUV Go Up After Treatment?
Your next step
Talk to an oncologist about your scan
Your PET-CT report read by a senior oncologist, explained in plain language, with a free 45-minute consultation.
Common questions
Frequently asked questions
What is the difference between complete metabolic response and complete remission?
These terms overlap but come from different types of assessment. Complete metabolic response is a PET-CT finding — it means no abnormal metabolic activity was detected on that scan. Complete remission is a broader clinical term that may combine imaging, symptoms, and blood results. Whether your oncologist uses one term or the other depends on your cancer type and the criteria they are applying. Ask which term appears in your record and what it means for your follow-up plan.
Does residual disease mean my treatment did not work?
Not necessarily. A partial response — where the cancer shrank substantially but was not fully eliminated on imaging — is a recognised outcome for certain cancers, and for some it remains within an acceptable range. Whether that result is sufficient or whether further treatment is needed depends on your cancer type, the degree of the residual, and your overall condition. Your oncologist will tell you where your result sits within the expected range for your cancer.
Can scar tissue look like cancer on a scan?
Yes, and this is one of the most common reasons oncologists order further assessment rather than acting immediately on a residual finding. Scar tissue and dead tumour cells can appear on PET-CT or MRI in ways that are difficult to distinguish from living disease without additional information. A biopsy, a comparison with earlier scans, or a repeat scan after an interval can help clarify what the residual represents. If your report notes residual and you are unsure, ask directly whether the finding is confirmed active disease or something the team is still characterising.
How long after treatment is the response assessment scan done?
Timing varies by cancer type and treatment. Scanning too soon after chemotherapy or radiation can produce misleading results — treatment-related inflammation appears active on PET-CT and can look similar to disease. Most guidelines recommend waiting several weeks after the final treatment before the response assessment scan, though your oncologist will set the specific timing for your situation. Your report should note when the scan was done relative to the end of treatment.
Does a complete metabolic response mean the same thing for every cancer?
No. The meaning and implications of a CMR differ substantially between cancer types. In some lymphomas, a CMR after initial treatment guides whether further therapy is needed and is assessed using the Deauville score. In solid tumours the criteria and implications are different. Ask your oncologist what a CMR result means specifically for your cancer type, stage, and treatment regimen — the same finding carries different weight in different settings.
My report says 'no evidence of residual disease' — is that the same as complete metabolic response?
These phrases overlap but come from different scan types. 'No evidence of residual disease' is often used on CT or MRI reports to mean no visible mass or abnormal tissue was found. 'Complete metabolic response' is the PET-CT term — no abnormal metabolic activity detected. Both describe an absence of detectable disease on imaging, but the specific meaning depends on which scan was used and the criteria applied. Your oncologist will tell you which applies to your report.